154 related articles for article (PubMed ID: 32461377)
1. Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer.
Zheng R; Jia J; Guan L; Yuan H; Liu K; Liu C; Ye W; Liao Y; Lin S; Huang O
Aging (Albany NY); 2020 May; 12(10):8893-8912. PubMed ID: 32461377
[TBL] [Abstract][Full Text] [Related]
2. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance.
Xie C; Zhang LZ; Chen ZL; Zhong WJ; Fang JH; Zhu Y; Xiao MH; Guo ZW; Zhao N; He X; Zhuang SM
Hepatology; 2020 May; 71(5):1660-1677. PubMed ID: 31509261
[TBL] [Abstract][Full Text] [Related]
3. Down-Regulation of LOC645166 in T Cells of Ankylosing Spondylitis Patients Promotes the NF-κB Signaling
Yu HC; Huang KY; Lu MC; Huang Tseng HY; Liu SQ; Lai NS; Huang HB
Front Immunol; 2021; 12():591706. PubMed ID: 33717069
[TBL] [Abstract][Full Text] [Related]
4. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
Chang L; Hu Z; Zhou Z; Zhang H
Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
[TBL] [Abstract][Full Text] [Related]
5. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
Li S; Jiang F; Chen F; Deng Y; Pan X
J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
[TBL] [Abstract][Full Text] [Related]
6. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
[TBL] [Abstract][Full Text] [Related]
7. Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells.
Huang L; Zeng L; Chu J; Xu P; Lv M; Xu J; Wen J; Li W; Wang L; Wu X; Fu Z; Xie H; Wang S
Mol Med Rep; 2018 Jul; 18(1):243-253. PubMed ID: 29749447
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1.
Wang Y; Zhou P; Li P; Yang F; Gao XQ
Bioengineered; 2020 Dec; 11(1):536-546. PubMed ID: 32345117
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer.
Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S
Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
11. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
Contreras-Espinosa L; Alcaraz N; De La Rosa-Velázquez IA; Díaz-Chávez J; Cabrera-Galeana P; Rebollar-Vega R; Reynoso-Noverón N; Maldonado-Martínez HA; González-Barrios R; Montiel-Manríquez R; Bautista-Sánchez D; Castro-Hernández C; Alvarez-Gomez RM; Jiménez-Trejo F; Tapia-Rodríguez M; García-Gordillo JA; Pérez-Rosas A; Bargallo-Rocha E; Arriaga-Canon C; Herrera LA
J Mol Diagn; 2021 Oct; 23(10):1306-1323. PubMed ID: 34358678
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis.
Wang Y; Xin D; Zhou L
Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
[TBL] [Abstract][Full Text] [Related]
17. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.
Ma S; Yang D; Liu Y; Wang Y; Lin T; Li Y; Yang S; Zhang W; Zhang R
Aging (Albany NY); 2018 Aug; 10(8):2062-2078. PubMed ID: 30144787
[TBL] [Abstract][Full Text] [Related]
18. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
19. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
Shang C; Guo Y; Zhang J; Huang B
Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
[TBL] [Abstract][Full Text] [Related]
20. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
